Drug Development & Clinical Trials

Latest updates on clinical research, trial phases, FDA approvals, and therapeutic breakthroughs.

5 Articles

Updated Weekly

Cell And Gene Therapy Manufacturing Market Size, Report 2035

The cell and gene therapy manufacturing market was valued at USD 134.48B in 2024, projected to reach USD 834.1B by 2035, growing at a CAGR of 15.5%.

News

Cell and Gene Therapy Manufacturing Market Surges Beyond $834.1B by 2035

The global cell and gene therapy manufacturing market will surpass $834.1B by 2035, driven by demand, bioprocessing advances, and regulatory growth.

News

Preclinical CRO Market Thrives at $ 28.06B by 2035

Explore in-depth research on the preclinical CRO market, including size, segmentation, regional analysis, growth drivers, and outsourcing trends.

Press-release

Preclinical CRO Market Size to Hit USD 28.06 Billion by 2035

The Preclinical CRO Market around the globe was worth USD 10.02 billion in 2024 and is anticipated to reach USD 7.08 billion during the forecast period of 3035, growing at a CAGR of 9.2%.

Press-release

Cell and Gene Therapy Manufacturing Market Size & Outlook

Cell and Gene Therapy Manufacturing Market is led by Cell Therapy Manufacturing holding a 60.19% share in 2023, including stem and non-stem cell therapies.